B
Bicycle Therap - ADR (BCYC)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Bicycle Therap - ADR (BCYC)
Bicycle Therapeutics PLC, formerly Bicycle Therapeutics Limited, is a clinical-stage biopharmaceutical company. The Company is focused on developing a class of medicines for diseases. The Company’s lead product candidate, BT1718, is a Bicycle Toxin C... Read more
- USD8.00
- USD8.09
- USD7.77
- USD28.67
- -6.30%
- 20M
- 256.51k
- 271.74k
- 355M
- 6.10
- -60.70%
Stock News
yesterday
Levi's CEO Michelle Gass says strong international business helps ward off tariff impact
CNBC
yesterday
Nvidia officially gets its $4 trillion finish. Here’s what could come next.
MarketWatch
yesterday
Levi Strauss raises sales guidance, says it will absorb some tariff costs for now
CNBC
yesterday
Business class+? Delta says segmentation is coming to high-end cabins
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
